Baseline characteristics
In total, all of the 100 approached patients orally consented to participate in this study. For all included patients (mean age 73.3 (SD±7.9) years, 64% female) the three questionnaires (MARS-5, BMQ-S and side effects) were administered and completed. The baseline characteristics are depicted in table 1. Most 81 % of the patients were on DOAC therapy for the indication atrial fibrillation while edoxaban (36%) and rivaroxaban (31%) were used more often than apixaban (19%) and dabigatran (14%).
Table 1. Baseline characteristics